Results 171 to 180 of about 8,502,687 (299)

Work Motivation of Primary Health Workers in China: The Translation of a Measurement Scale and Its Correlation with Turnover Intention. [PDF]

Risk Manag Healthc Policy, 2022
Li H, Yuan B, Yu Y, Li J, Meng Q.
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Development of a Functioning Measurement Scale for the South Korean Population Using the Korea National Health and Nutrition Examination Survey. [PDF]

Int J Public Health
Kim J, Fellinghauer C, Hodel J, Cho Y, Kim W, Sabariego C.   +5 more
europepmc   +1 more source

Cultural Adaptation and Validation of the Premature Infant Pain Profile-Revised (PIPP-R) Pain Measurement Scale: Research Protocol. [PDF]

Int J Environ Res Public Health, 2022
Núñez-López I, Collados-Gómez L, Abalo R, Martínez-Pérez P, Moreno-Vicente Á, Cid-Expósito MG.   +5 more
europepmc   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

A diffusion of innovations measurement scale for reinvention, relative advantage, compatibility, complexity, trialability and observability. [PDF]

PLoS One
Overbye-Thompson H, Hamilton KA.
europepmc   +1 more source

Differences between Novice and Expert Raters Assessing Trunk Control Using the Trunk Control Measurement Scale Spanish Version (TCMS-S) in Children with Cerebral Palsy. [PDF]

J Clin Med, 2023
López-Ruiz J, Estrada-Barranco C, Giménez-Mestre MJ, Villarroya-Mateos I, Martín-Casas P, López-de-Uralde-Villanueva I.   +5 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Correction: Women's experiences of and satisfaction with childbirth: Development and validation of a measurement scale for low- and middle-income countries. [PDF]

PLoS One
PLOS One Staff.
europepmc   +1 more source

Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer. [PDF]

Front Oncol, 2023
Zhou X, Liu Y, Tan J, Hu L, Chen H, Wan C.   +5 more
europepmc   +1 more source